16 Del. C. § 2601: Short title; definitions.

(a) This chapter shall be known and may be cited as the “Childhood Lead Poisoning Prevention Act.”

(b) For purposes of this chapter:

(1) “Department” means the Department of Health and Social Services.

(2) “Elevated blood lead level” means a blood lead level that meets or exceeds 3.5 micrograms per deciliter or a blood lead level established by the federal Centers for Disease Control and Prevention as the federal Centers for Disease Control and Prevention’s blood lead reference value, whichever is lower.

(3) “Lead-exposure site” means the location where a child was most likely exposed to lead.

(4) “Program,” used as a proper noun, means the Delaware State Lead-Based Paint Program created under § 2607 of this title.

(5) “Screening” means a capillary blood lead test, including where a drop of blood is taken from a finger or heel of the foot.

(6) “Testing” means any of the following:

a. A venous blood test in which blood is drawn from a vein.

b. Two capillary blood screenings collected within 12 weeks of each other.